In-111 DTPA (AnazaoHealth Corporation)
Welcome to the PulseAid listing for the In-111 DTPA drug offered from AnazaoHealth Corporation. This Lead Chelating Activity [MoA],Lead Chelator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AnazaoHealth Corporation |
NON-PROPRIETARY NAME: | In-111 DTPA |
SUBSTANCE NAME: | INDIUM IN-111 PENTETATE DISODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Lead Chelating Activity [MoA],Lead Chelator [EPC] |
ROUTE: | INTRATHECAL |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2012-06-19 |
END MARKETING DATE: | 0000-00-00 |
In-111 DTPA HUMAN PRESCRIPTION DRUG Details:
Item Description | In-111 DTPA from AnazaoHealth Corporation |
LABELER NAME: | AnazaoHealth Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3.75(mCi/1.5mL) |
START MARKETING DATE: | 2012-06-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51808-125_0e714ae6-396c-4488-868e-bfe5fd446f3f |
PRODUCT NDC: | 51808-125 |
APPLICATION NUMBER: | |
Other INDIUM IN-111 PENTETATE DISODIUM Pharmaceutical Manufacturers / Labelers: